Antoniou, A., Pharoah, P. D., Narod, S., et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics, 72(5), 1117–1130.Google Scholar

Bleiker, E. M., Esplen, M. J., Meiser, B., et al. (2013). 100 years Lynch syndrome: what have we learned about psychosocial issues? Familial Cancer 2, 325–339.CrossRefGoogle Scholar

Burke, W., Daly, M. & Garber, J. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. Cancer Genetics Study Consortium. Journal of the American Medical Association 277, 997–1003.CrossRefGoogle Scholar

Chen, S. & Parmigiani, G.(2007). Meta-analysis of BRCA1 and BRCA2 penetrance. Journal of Clinical Oncology, 25(11), 1329–1333.CrossRefGoogle ScholarPubMed

Chompret, A. (2002). The Li-Fraumeni syndrome. Biochemie, 84, 75–82.Google Scholar

Chompret, A., Brugieres, L., Ronsin, M., et al. (2000). P53 germline mutations in childhood cancers and cancer risk for carrier individuals. British Journal of Cancer, 82, 1932–1937.Google Scholar

Cousens, N., Kaur, R., Meiser, B., et al. (2016). Community attitudes towards a Jewish community BRCA1/2 testing program. Familial Cancer, epublication ahead of print.Google Scholar

Daly, M. B., Pilarski, R., Axilbund, J. E., et al. (2015). Genetic/familial high-risk assessment: breast and ovarian, version 2.2015. Journal of the National Comprehensive Cancer Network 14, 153–162.Google Scholar

Douma, K. F., Bleiker, E. M., Aaronson, N. K., et al. (2010). Long-term compliance with endoscopic surveillance for familial adenomatous polyposis. Colorectal Disease, 12, 1198–1207.Google Scholar

Elrick, A., Ashida, S., Ivanovich, J., et al. (2017). Psychosocial and clinical factors associated with family communication of cancer genetic test results among women diagnosed with breast cancer at a young age. Journal of Genetic Counseling, 26(1), 173–181.Google Scholar

Forman, A. D. & Hall, M. J. (2009). Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Breast Journal, 15 (Suppl. 1), S56–S62.Google Scholar

Glassey, R., Ives, A., Saunders, C., et al. (2016). Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy: a review of the literature. Breast, 28, 130–135.Google Scholar

Graves, K. D., Vegella, P., Poggi, E. A., et al. (2012). Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice. Cancer Epidemiology, Biomarkers & Prevention, 21(3): 445–455.Google Scholar

Hirschberg, A. M., Chan-Smutko, G. & Pirl, W. F. (2015). Psychiatric implications of cancer genetic testing. Cancer, 121, 341–360.Google Scholar

Howard, A. F., Balneaves, L. G. & Bottorff, J. L. (2009). Women’s decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: a systematic review. Journal of Genetic Counseling, 18, 578–597Google Scholar

Jasperson, K. W., Tuohy, T. M., Neklason, D. W., et al. (2010). Hereditary and familial colon cancer. Gastroenterology, 138, 2044–2058.Google Scholar

Kinney, A. Y., Butler, K. M., Schwartz, M. D., et al. (2014). Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial. Journal of the National Cancer Institute, 106, dju328.Google Scholar

Lesko, L. J. & Schmidt, S. (2013). Clinical implementation of genetic testing in medicine: a US regulatory science perspective. British Journal of Clinical Pharmacology, 77, 606–611.Google Scholar

Lynch, H. T., Lynch, P. M., Lanspa, S. J., et al. (2009). Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clinical Genetics , 76, 1–18.CrossRefGoogle ScholarPubMed

Malkin, D., Li, F. P., Strong, L. C., et al. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233–1238.Google Scholar

Malkin, D., Garber, J. E., Strong, L., et al. (2016). The cancer predisposition revolution: how was the inherited basis of cancer foreshadowed? Science, 352, 1052–1053.CrossRefGoogle Scholar

Meiser, B., Quinn, V. F., Gleeson, M., et al. (2016). When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer. European Journal of Human Genetics, epublication in advance of print.Google Scholar

Monahan, K. J. & Hopkins, L. ( 2016). Diagnosis and management of hereditary gastric cancer. Recent Results in Cancer Research, 205, 45–60.Google Scholar

Nichols, K. E., Malkin, D., Garber, J. E., et al. (2001). Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer, Epidemiology, Biomarkers and Prevention, 10, 83–87.Google Scholar

Noar, S. M., Althouse, B. M., Ayers, J. W., Francis, D. B. & Ribisl, K. M. (2015). Cancer information seeking in the digital age: effects of Angelina Jolie’s prophylactic mastectomy announcement. Medical Decision Making, 35(1), 16–21.CrossRefGoogle ScholarPubMed

Patenaude, A. F. (2012), Prophylactic Mastectomy: Insights from Women who Chose to Reduce Their Risk. Santa Barbara, CA; Praeger.Google Scholar

Patenaude, A. F. & Schneider, K. A. (2016). Issues arising in psychological consultations to help parents talk to minor and young adult children about their cancer genetic test result: a guide to providers. Journal of Genetic Counseling, 26, 251–260.Google Scholar

Ringwald, J., Wochnowski, C., Bosse, K., et al. (2016). Psychological distress, anxiety and depression of cancer-affected BRCA1/2 mutation carriers: a systematic review. Journal of Genetic Counseling, epublished ahead of print.CrossRefGoogle Scholar

Robinson, L. S., Hendrix, A., Xie, X. J. et al., (2015). Prediction of cancer prevention: from mammogram screening to identification of BRCA1/2 mutation carriers in underserved populations. EBioMedicine, 21, 1827–1833.Google Scholar

Rodriguez, V. M., Corona, R., Bodurtha, J. N., et al. (2016). Family ties: the role of family context in family health history communication about cancer. Journal of Health Communication, 21, 346–355.Google Scholar

Roussi, P. & Miller, S. M. (2014). Monitoring style of coping with cancer related threats: a review of the literature. Journal of Behavioral Medicine, 37(5), 931–954.Google Scholar

Stan, D. L., Schuster, L. T. & Wick, M. J. (2013). Challenging and complex decisions in the management of the BRCA mutation carrier. Journal of Women’s Health, 22, 825–834.Google Scholar

Syngal, S., Brand, R. E., Church, J. M., et al. (2015). ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. American Journal of Gastroenterology, 110, 223–262.Google Scholar

Tercyak, K. P., Mays, D., DeMarco, T. A., et al. (2013). Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children. Cancer Epidemiology, Biomarkers & Prevention, 22(7), 1260–1266.Google Scholar

van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., et al. (2006). Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing. Annals of Oncology, 17(7), 1090–1095.Google Scholar

Villani, A., Tabori, U., Schiffman, J., et al. (2011). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncology, 12, 559–567.Google Scholar

Wakefield, C. E., Hanlon, L. V., Tucker, K. M., et al. (2016). The psychological impact of genetic information on children: a systematic review. Genetics in Medicine, 18(8): 755–762.CrossRefGoogle ScholarPubMed